AbbVie Reports Second-Quarter 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. OPCH
5. BBIO
6. NVDA
7. GOOGL
8. CHRW
9. AMD
10. STZ

Go back to AbbVie Reports Second-Quarter 2023 Financial Results

AbbVie (ABBV) climbs after raising full-year earnings guidance

July 27, 2023 9:09 AM EDT

AbbVie (NYSE: ABBV) shares are climbing premarket on the back of its second-quarter profit and revenue beat. The company also raised earnings per share guidance.

The pharmaceutical firm reported Q2 EPS of $2.91, $0.04 better than the analyst estimate of $2.87. Revenue for the quarter... More

AbbVie (ABBV) Tops Q2 EPS by 4c, Raises FY Guidance

July 27, 2023 7:39 AM EDT

AbbVie (NYSE: ABBV) reported Q2 EPS of $2.91, $0.04 better than the analyst estimate of $2.87. Revenue for the quarter came in at $13.87 billion versus the consensus estimate of $13.51 billion.

GUIDANCE:

AbbVie sees FY2023 EPS of $10.90-$11.10, versus the consensus of $10.85.

Raises 2023... More